Charles A. Nicolette
Chief Executive Officer at CoImmune, Inc.
Charles A. Nicolette active positions
| Companies | Position | Start | End |
|---|---|---|---|
CoImmune, Inc.
 CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Career history of Charles A. Nicolette
Former positions of Charles A. Nicolette
| Companies | Position | Start | End |
|---|---|---|---|
| ARGOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2003-06-30 | 2018-11-29 |
Genzyme Molecular Oncology
 Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis. | Corporate Officer/Principal | 1996-12-31 | 2002-12-31 |
| Antigen Discovery | Director/Board Member | 1996-12-31 | 2002-12-31 |
Training of Charles A. Nicolette
| The State University of New York | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis. | Health Technology |
| Antigen Discovery | |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Charles A. Nicolette
- Experience
